2021年5月21日(金) 14:40 〜 16:40 第7会場 (国立京都国際会館 1F Room D)

座長：小池 春樹(名古屋大学病院 脳神経内科),山﨑 亮(九州大学大学院医学研究院神経内科学)

In recent years, in chronic inflammatory demyelinating polyradiculitis (CIDP), autoreactive antibodies have been found in succession in a part of the patients, and the unique mechanism of each antibody is becoming clear. In this session, we will discuss disease classification based on a new molecular mechanism and treatment selection based on it, without being bound by the conventional clinical distinction of GBS / CIDP.